For comments, suggestions
Created with Raphaël 2.1.0 23.11.2016 Filing date 23.05.2017 Validation fee payment 30.09.2017 (A1) Patent application published 06.06.2018 AGEPI application filing date 30.09.2018 (T2) Translation of the validated European patent 23.11.2022 Valid until 31.08.2023 (MM4E) Forfeiture of rights 30.06.2024 (MM4E) Forfeiture of rights

Patent lapsed


(210)Number of the EPO application16804858
(220)Filing date of the EPO application2016.11.23
(80)EPO patent specification publication (B)EPB nr. 11/2018, 2018.03.14
(110)EPO patent number3209309
(11)Number of the documentMD 3209309 T2
(21)Number of the applicatione 2017 0064
(71)Name(s) of applicant(s), code of the country4D Pharma Research Limited, GB;
(72)Name(s) of inventor(s), code of the countryMULDER Imke Elisabeth, GB;
HOLT Amy Beth, GB;
MCCLUSKEY Seanin Marie, GB;
LENNON Grainne Clare, GB;
AHMED Suaad, GB;
(73)Name(s) of owner(s), code of the country4D Pharma Research Limited, GB;
(54)Title of the inventionCompositions comprising bacterial strains
(13)Kind-of-document code T2
(51)International Patent Classification A61K 35/74 (2015.01.01); A61P 29/00 (2006.01.01); A61P 35/00 (2006.01.01)
(19)CountryGB
(41)Date of publication of the application2017.09.30
(49)Date of publication of the translation of the validated European patent specification2018.09.30
(30)Priority201520638, 2015.11.23, GB
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/GB2016/053677, 2016.11.23
(87)International publicationWO 2017/089795, 2017.06.01
Up
/Inventions/details/3209309